Post-transplant Hyperuricemia as a Cardiovascular Risk Factor

被引:5
|
作者
Uyar, M. Erkmen [1 ]
Sezer, S. [1 ]
Bal, Z. [1 ]
Guliyev, O. [1 ]
Tutal, E. [1 ]
Kulah, E. [1 ]
Genctoy, G. [1 ]
Acar, N. Ozdemir [1 ]
Haberal, M. [2 ]
机构
[1] Baskent Univ, Dept Nephrol, Antalya, Turkey
[2] Baskent Univ, Dept Gen Surg, TR-06490 Ankara, Turkey
关键词
SERUM URIC-ACID; KIDNEY-TRANSPLANT RECIPIENTS; RENAL-DISEASE; GRAFT DYSFUNCTION; PATHOGENETIC ROLE; HYPERTENSION; ASSOCIATION; SURVIVAL; GOUT;
D O I
10.1016/j.transproceed.2015.03.004
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Purpose. Uric acid is known to impair endothelial cell function and to stimulate the development of renal interstitial fibrosis. The aim of this study was to evaluate the association between first-year hyperuricemia with graft dysfunction and the development of cardiovascular risk disorders in renal transplant recipients. Methods. One hundred kidney transplant recipients (31 female, 45.9 +/- 9.6 post-transplantation months) with normal graft functions were enrolled. The clinical biochemical parameters in the first post-transplantation year were retrospectively recorded and searched for the predictive value in yearly determined graft function and association with cross-sectionally analyzed cardiovascular parameters, including body composition analyses, ambulatory blood pressure monitoring data, and pulse wave velocity. Hyperuricemia was defined as an uric acid level of >= 6.5 mg/dL that persisted for at least 2 consecutive tests. Results. One year after transplantation, 37% of subjects had hyperuricemia. According to cross-sectional data, sagittal abdominal diameter (P = .002) and hip circumferences (P = .013) were significantly higher in hyperuricemic patients than in normouricemic ones. Hyperuricemic patients had higher fat (P = .014) and muscle mass (P = .016) than normouremic patients. Hyperuricemic patients had significantly higher mean systolic BP (P = .044) than normouremic patients. Hyperuricemic patients had significantly higher pulse wave velocity levels (P = .0001) and left ventricular mass index (P = .044) than normouremic patients. The yearly decline in estimated glomerular filtration rate levels was significantly higher in hyperuricemic patients (P = .0001) than in normouricemic ones. Conclusion. Post-transplantation hyperuricemia is associated with hypertension, arterial stiffness, and dyslipidemia; it should be accepted not only as a marker for renal allograft dysfunction but also as a cardiovascular risk factor in renal transplant recipients.
引用
收藏
页码:1146 / 1151
页数:6
相关论文
共 50 条
  • [31] In response: Hyperuricemia as a risk factor for cardiovascular disease
    Borghi, Claudio
    Cicero, Arrigo F. G.
    [J]. EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2015, 13 (01) : 21 - 22
  • [32] Pancreatic steatosis is an independent risk factor for post-transplant diabetes mellitus in kidney transplant patients
    Hasbal, Nuri Baris
    Copur, Sidar
    Peltek, Ibrahim B.
    Mutlu, Ali
    Atalay, Hande Ozen
    Kesgin, Yavuz E.
    Karakaya, Afak Durur
    Siriopol, Dimitrie
    Kocak, Burak
    Kanbay, Mehmet
    [J]. CLINICAL TRANSPLANTATION, 2024, 38 (01)
  • [33] Pre-Transplant Coronary Artery Disease: An Underestimated Risk Factor for Post-Transplant Mortality?
    Khadzhynov, D.
    Halleck, F.
    Lehner, L.
    Duerr, M.
    Kleinsteuber, A.
    Budde, K.
    Staeck, O.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 571 - 572
  • [34] Pre-liver transplant cardiovascular risk profile and correlation with early post-transplant cardiac events
    Martini, S.
    Risso, A.
    Mosso, E.
    Calvo, F.
    Chiala, C.
    Tandoi, F.
    Marra, W. Grosso
    Panio, A.
    Ottobrelli, A.
    Saracco, G. M.
    Romagnoli, R.
    Lavezzo, B.
    [J]. DIGESTIVE AND LIVER DISEASE, 2019, 51 : E52 - E52
  • [35] Associations between pre-kidney-transplant risk factors and post-transplant cardiovascular events and death
    Aalten, Jeroen
    Hoogeveen, Ellen K.
    Roodnat, Joke I.
    Weimar, Willem
    Borm, George F.
    de Fijter, Johan W.
    Hoitsma, Andries J.
    [J]. TRANSPLANT INTERNATIONAL, 2008, 21 (10) : 985 - 991
  • [36] Post Transplant Hyperuricemia: Incidence and Risk Factors.
    Mazzali, M.
    Sesti, G.
    Rivelli, G.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 521 - 521
  • [37] Post Transplant Hyperuricemia: Incidence and Risk Factors.
    Mazzali, M.
    Sesti, G.
    Rivelli, G.
    [J]. TRANSPLANTATION, 2014, 98 : 521 - 521
  • [38] POSTTRANSPLANT HYPERURICEMIA AS A CARDIOVASCULAR RISK FACTOR: CORRELATION BETWEEN CARDIOVASCULAR RISK FACTORS
    Sezer, Siren
    Tutal, Emre
    Bal, Zeynep
    Uyar, Mehtap Erkmen
    Haberal, Mehmet
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2016, 31 : 313 - 313
  • [39] Posttransplant hyperuricemia as a cardiovascular risk factor: Correlation between cardiovascular risk factors
    Sezer, Siren
    Tutal, Emre
    Bal, Zeynep
    Erkmen, Mehtap
    Moray, Gokhan
    Colak, Turan
    Haberal, Mehmet
    [J]. TRANSPLANTATION, 2016, 100 (07) : S306 - S306
  • [40] Risk Factors and Management of Osteoporosis Post-Transplant
    Kovvuru, Karthik
    Kanduri, Swetha Rani
    Vaitla, Pradeep
    Marathi, Rachana
    Gosi, Shiva
    Anton, Desiree F. Garcia
    Rivera, Franco H. Cabeza
    Garla, Vishnu
    [J]. MEDICINA-LITHUANIA, 2020, 56 (06): : 1 - 18